| Literature DB >> 34204372 |
Mircea Tampa1,2, Simona Roxana Georgescu1,2, Madalina Irina Mitran3, Cristina Iulia Mitran3, Clara Matei1, Ana Caruntu4,5, Cristian Scheau6, Ilinca Nicolae2, Andreea Matei6, Constantin Caruntu6,7, Carolina Constantin8,9, Monica Neagu8,9,10.
Abstract
Basal cell carcinoma (BCC) is the most common skin malignancy, which rarely metastasizes but has a great ability to infiltrate and invade the surrounding tissues. One of the molecular players involved in the metastatic process are matrix metalloproteinases (MMPs). MMPs are enzymes that can degrade various components of the extracellular matrix. In the skin, the expression of MMPs is increased in response to various stimuli, including ultraviolet (UV) radiation, one of the main factors involved in the development of BCC. By modulating various processes that are linked to tumor growth, such as invasion and angiogenesis, MMPs have been associated with UV-related carcinogenesis. The sources of MMPs are multiple, as they can be released by both neoplastic and tumor microenvironment cells. Inhibiting the action of MMPs could be a useful therapeutic option in BCC management. In this review that reunites the latest advances in this domain, we discuss the role of MMPs in the pathogenesis and evolution of BCC, as molecules involved in tumor aggressiveness and risk of recurrence, in order to offer a fresh and updated perspective on this field.Entities:
Keywords: BCC; MMP; TIMP; invasion; tumor progression
Year: 2021 PMID: 34204372 DOI: 10.3390/biom11060903
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X